Marie-Jacqueline Reisener

Marie-Jacqueline Reisener

Auto-generated profile, based on publicly available information

Marie-Jacqueline Reisener

Spine Care Institute, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2022 in The Spine Journal
Verified
Journal Article
Closed access
CJConor Jones
Conor Jones
IOIchiro Okano
Ichiro Okano
AAArtine Arzani
Artine Arzani
YDYusuke Dodo
Yusuke Dodo
MMManuel Moser
Manuel Moser
AHAlexander P. Hughes
Alexander P. Hughes

12 July 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MRMarie Reisener
Marie Reisener
CPCarsten Perka
Carsten Perka
Background. Culture-negative periprosthetic joint infections (CN PJI) have not been well studied, and due to the lack of consensus on PJI, especially with culture-negative infections, there are considerable uncertainties. Due to the challenging clinical issue of CN PJI the aim of this systematic review is to describe incidence, diagnosis, and treatment outcomes based on the current literature on CN PJI.Hypothesis.The review is designed to assess the formal hypothesis that CN PJI of the hip and knee have a poorer outcome when compared with culture-positive ones.Study Design.It is systematic review with level of evidence 3.Methods.EMBASE, MEDLINE, and the Cochrane Library were searched electronically in January 2018. All studies regarding CN PJI of the hip or knee published in English or German with a minimum of 10 patients were included. Afterwards, the authors performed a descriptive analysis of diagnosis and treatment outcome.Result.Eight studies were identified that met the inclusion criteria. The incidence of CN PJI in the hip or knee ranged from 7% to 42 %. The included studies were pooled to give an overall incidence rate estimate of 11 % [95% confidence interval (CI): 10-12] based on a random-effects model. The most common surgical intervention was the two-stage revision of prosthesis with 283 patients. Postoperatively, the majority of patients received vancomycin as the antibiotic treatment, alone or in combination with other antibiotics. The rate of succesfully treated infections varied from 85% to 95 % in all included studies. The two-stage exchange arthroplasty had the best outcome, based on the infection-free survival rate of 95%, five years after treatment.Conclusions.We conclude that CN PJI have the same or even better results than culture-positive infections. Nonetheless, a standardized diagnostic protocol and evidence-based treatment strategies for CN PJI should be implemented for further studies.

30 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
PKPaul Köhli
Paul Köhli
Ellen OttoEllen Otto
Ellen Otto
DJDenise Jahn
Denise Jahn
MRMarie-Jacqueline Reisener
Marie-Jacqueline Reisener
JAJessika Appelt
Jessika Appelt
STSerafim Tsitsilonis
Serafim Tsitsilonis
Traumatic spinal cord injury (TSCI), commonly caused by high energy trauma in young active patients, is frequently accompanied by traumatic brain injury (TBI). Although combined trauma results in inferior clinical outcomes and a higher mortality rate, the understanding of the pathophysiological interaction of co-occurring TSCI and TBI remains limited. This review provides a detailed overview of the local and systemic alterations due to TSCI and TBI, which severely affect the autonomic and sensory nervous system, immune response, the blood–brain and spinal cord barrier, local perfusion, endocrine homeostasis, posttraumatic metabolism, and circadian rhythm. Because currently developed mesenchymal stem cell (MSC)-based therapeutic strategies for TSCI provide only mild benefit, this review raises awareness of the impact of TSCI–TBI interaction on TSCI pathophysiology and MSC treatment. Therefore, we propose that unravelling the underlying pathophysiology of TSCI with concomitant TBI will reveal promising pharmacological targets and therapeutic strategies for regenerative therapies, further improving MSC therapy.

1 October 2021 in World Neurosurgery
Verified
Journal Article
Closed access
MRMarie-Jacqueline Reisener
Marie-Jacqueline Reisener
IOIchiro Okano
Ichiro Okano
JZJiaqi Zhu
Jiaqi Zhu
SSStephan N. Salzmann
Stephan N. Salzmann
CMCourtney Ortiz Miller
Courtney Ortiz Miller
AHAlexander P. Hughes
Alexander P. Hughes